|
MAY ANTAGONISE THE EFFECTS OF CARBACHOL
|
MAY ANTAGONISE THE EFFECTS OF CARBACHOL
|
MAY ANTAGONISE THE EFFECTS OF CARBACHOL
|
MAY ANTAGONISE THE EFFECTS OF CARBACHOL
|
MAY ANTAGONISE THE EFFECTS OF CARBACHOL
|
MAY ANTAGONISE THE EFFECTS OF CARBACHOL
|
MAY ANTAGONISE THE EFFECTS OF CARBACHOL
|
MAY ANTAGONISE THE EFFECTS OF CARBACHOL
|
MAY ANTAGONISE THE EFFECTS OF CARBACHOL
|
MAY ANTAGONISE THE EFFECTS OF CARBACHOL
|
MAY ANTAGONISE THE EFFECTS OF CARBACHOL
|
MAY ANTAGONISE THE EFFECTS OF CARBACHOL
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NSAIDS CONCURRENT ADMINISTRATION MAY CAUSE CARBACHOL INEFFECTIVE
|
NSAIDS CONCURRENT ADMINISTRATION MAY CAUSE CARBACHOL INEFFECTIVE
|
NSAIDS CONCURRENT ADMINISTRATION MAY CAUSE CARBACHOL INEFFECTIVE
|
NSAIDS CONCURRENT ADMINISTRATION MAY CAUSE CARBACHOL INEFFECTIVE
|
NSAIDS CONCURRENT ADMINISTRATION MAY CAUSE CARBACHOL INEFFECTIVE
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
NSAIDS CONCURRENT ADMINISTRATION MAY LEAVE THE DRUG INEFFECTIVE IN PATIENTS TREATED WITH LOCAL NSAIDS
|
CYCLOPENTOLATE MAY INTERFERE WITH THE ANTIGLAUCOMA ACTION OF CARBACHOL OR PILOCARPINE
|
PARASYMPATHOMIMETICS MAY COUNTERACT EACH OTHER EFFECTS
|
CO-ADMINISTRATION MAY LEAD TO INCREASED PARASYMPHATHOMIMETIC EFFECT CAUSING BRADYCARDIA, HYPOTENSION, A-V CONDUCTION ABNORMALITIES, FLUSHING, DIARRHOEA, ABDOMINAL PAIN, INCREASED SALIVATION ETC
|